Press Releases

Jul 28, 2015 3:45am EDT

CollPlant Names Shomrat Shurtz Senior Director of Business Development

Jul 20, 2015 4:01am EDT

CollPlant Reports Positive Interim Trial Results for Vergenix™STR, for the Treatment of Tendinopathy

Jul 13, 2015 4:00am EDT

CollPlant Executes Non-binding Term Sheet to Develop and Commercialize a Novel Product for Spinal Fusion and Trauma Indications in Collaboration with Leading US Partner

Mar 19, 2015 8:57am EDT

CollPlant Reports Positive Interim Trial Results for Vergenix®FG Wound Healing Gel

Mar 10, 2015 12:15pm EDT

CollPlant Appoints Ira Leiderman and Nira Dror to its Board of Directors

Jan 12, 2015 11:04am EST

Another Clinical Trial for CollPlant: Trials for Vergenix®STR Have Begun - a Human Collagen-based Product for Tendon Repair

Dec 01, 2014 7:00am EST

CollPlant Launched a Clinical Trial With Vergenix®FG; A Gel Based on a Human Collagen for the Treatment of Chronic Wounds

Sep 08, 2014 6:26am EDT

CollPlant Names Dr. Nadav Orr Vice President Research and Development

Jun 23, 2014 9:16am EDT

CollPlant Holds Intellectual Property Rights in USA - One of the Largest Target Markets for the Company's Products: US Patent Office Approves Patent for Company's Collagen Production Techniques

Jun 16, 2014 11:53am EDT

CollPlant Takes a Step Closer to Commercializing its Vergenix Flowable Gel Product for Treating Wounds: Receives Approval to Carry Out Clinical Trial